In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC ...
WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...
Under Sistani, the 61-year-old company bought a telehealth platform that connected patients with doctors who can prescribe weight-loss and diabetes drugs, including Ozempic and Wegovy ...
COMMENT: As a binge eater, Charlotte Cripps thought the slimming wonder drug would offer a miracle cure for her cravings. She ...
The media mogul has oft been the go-to girl for weight loss inspiration, tips, and tricks for years. So let's take a look at ...